Protein domains governing interactions between E2F, the retinoblastoma gene product, and human papillomavirus type 16 E7 protein. 1993

P S Huang, and D R Patrick, and G Edwards, and P J Goodhart, and H E Huber, and L Miles, and V M Garsky, and A Oliff, and D C Heimbrook
Department of Cancer Research, Merck Research Laboratories, West Point, Pennsylvania 19486.

Human papillomaviruses (HPVs) are the etiological agents for genital warts and contribute to the development of cervical cancer in humans. The HPV E7 gene product is expressed in these diseases, and the E7 genes from HPV types 16 and 18 contribute to transformation in mammalian cells. Mutation and deletion analysis of this gene suggests that the transforming activity of the protein product resides in the same domain as that which is directly involved in complex formation with the retinoblastoma gene product (pRB). This domain is one of two conserved regions (designated CRI and CRII) shared by E7 and other viral oncoproteins which bind pRB, including adenovirus E1A protein. Binding of HPV type 16 E7 protein to pRB has previously been shown to affect pRB's ability to bind DNA and to form complexes with other cellular proteins. In the current study, we map the functional interaction between E7 protein and pRB by monitoring the association between a 60-kDa version of the pRB, pRB60, and the cellular transcription factor E2F. We observe that CRII of E7 (amino acids 20 to 29), which completely blocks binding of full-length E7 protein, is necessary but not sufficient to inhibit E2F/pRB60 complex formation. While CRI of E1A (amino acids 37 to 55) appears to be sufficient to compete with E2F for binding to pRB60, the equivalent region of E7 is neither necessary nor sufficient. Only E7 fragments that contained both CRII and at least a portion of the zinc-binding domain (amino acids 60 to 98) inhibited E2F/pRB60 complex formation. These results suggest that pRB60 associates with E7 and E2F through overlapping but distinct domains.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009856 Oncogene Proteins, Viral Products of viral oncogenes, most commonly retroviral oncogenes. They usually have transforming and often protein kinase activities. Viral Oncogene Proteins,Viral Transforming Proteins,v-onc Proteins,Transforming Proteins, Viral,v onc Proteins
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D004268 DNA-Binding Proteins Proteins which bind to DNA. The family includes proteins which bind to both double- and single-stranded DNA and also includes specific DNA binding proteins in serum which can be used as markers for malignant diseases. DNA Helix Destabilizing Proteins,DNA-Binding Protein,Single-Stranded DNA Binding Proteins,DNA Binding Protein,DNA Single-Stranded Binding Protein,SS DNA BP,Single-Stranded DNA-Binding Protein,Binding Protein, DNA,DNA Binding Proteins,DNA Single Stranded Binding Protein,DNA-Binding Protein, Single-Stranded,Protein, DNA-Binding,Single Stranded DNA Binding Protein,Single Stranded DNA Binding Proteins
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic

Related Publications

P S Huang, and D R Patrick, and G Edwards, and P J Goodhart, and H E Huber, and L Miles, and V M Garsky, and A Oliff, and D C Heimbrook
May 1992, Molecular and cellular biology,
P S Huang, and D R Patrick, and G Edwards, and P J Goodhart, and H E Huber, and L Miles, and V M Garsky, and A Oliff, and D C Heimbrook
March 1994, The Journal of biological chemistry,
P S Huang, and D R Patrick, and G Edwards, and P J Goodhart, and H E Huber, and L Miles, and V M Garsky, and A Oliff, and D C Heimbrook
January 1993, The Journal of general virology,
P S Huang, and D R Patrick, and G Edwards, and P J Goodhart, and H E Huber, and L Miles, and V M Garsky, and A Oliff, and D C Heimbrook
June 2006, Cancer research,
P S Huang, and D R Patrick, and G Edwards, and P J Goodhart, and H E Huber, and L Miles, and V M Garsky, and A Oliff, and D C Heimbrook
April 1993, BioTechniques,
P S Huang, and D R Patrick, and G Edwards, and P J Goodhart, and H E Huber, and L Miles, and V M Garsky, and A Oliff, and D C Heimbrook
September 1991, Journal of virology,
P S Huang, and D R Patrick, and G Edwards, and P J Goodhart, and H E Huber, and L Miles, and V M Garsky, and A Oliff, and D C Heimbrook
April 1993, Oncogene,
P S Huang, and D R Patrick, and G Edwards, and P J Goodhart, and H E Huber, and L Miles, and V M Garsky, and A Oliff, and D C Heimbrook
September 1999, Molecular and cellular biology,
P S Huang, and D R Patrick, and G Edwards, and P J Goodhart, and H E Huber, and L Miles, and V M Garsky, and A Oliff, and D C Heimbrook
May 1992, Proceedings of the National Academy of Sciences of the United States of America,
P S Huang, and D R Patrick, and G Edwards, and P J Goodhart, and H E Huber, and L Miles, and V M Garsky, and A Oliff, and D C Heimbrook
March 2006, Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition,
Copied contents to your clipboard!